This free training program could be the stepping stone you need to pursue a career in medical journalism. Medscape Internal Medicine
Author: Medscape
Aphakic Kids’ Secondary Lens Implants Pose Risks
Implantation of a secondary intraocular lens in children with aphakic eye was associated with complications, refractive errors, and suboptimal visual acuity. Medscape Medical News
Cyclosporine Drops Ease Discomfort After Cataract Surgery
Prophylactic use of cyclosporine A cationic emulsion eye drops before cataract surgery led to less eye discomfort after the procedure in patients older than 75 years. Medscape Medical News
Teprotumumab Gives Lasting Relief from Thyroid Eye Disease
Nearly 2 years after their final teprotumumab transfusion, 82% of patients didn’t need further treatment. Medscape Medical News
Updated Guidelines for Dry Eye Syndrome
Linda Girgis, MD, on recent changes to the guidelines for managing patients with dry eye syndrome. MDedge
Risk Factors for Incident Diabetic Retinopathy in T1D
Duration of diabetes, systemic comorbidities, and use of medications to reduce blood pressure are common markers for present and incident DR in patients with T1D. Medscape Medical News
In the Future, a Robot Intensivist May Save Your Life
Dr Wilson comments on a unique closed-loop system that can resuscitate and stabilize trauma patients during transport to a higher level of care. Medscape
Triamcinolone Offers Relief in Thyroid Eye Disease
Percutaneous injection of triamcinolone improved margin reflex distance 1 and upper eyelid retraction in patients with thyroid eye disease. Medscape Medical News
Does EMTALA Apply to Pregnancy, Abortion? Ethicist Says Yes
Ethicist Art Caplan discusses abortion and the Emergency Medical Treatment and Labor Act (EMTALA). Medscape Business of Medicine
When It Comes to Medicine, ‘Women Are Not Small Men’
In her book Sex Cells, Phyllis Greenberger says doctors didn’t consider biological sex. If it was successful on a man, they’d blanketly use it on a woman. WebMD
Study of AI for Retina Disease Finds Many Unusable Images
A study using AI to detect diabetic retinopathy from retinal photos found primary care settings were three times more likely to capture unusable images than ophthalmology clinics. Medscape Medical News
Risks for Hydroxychloroquine Retinopathy Described in Detail
Including over 4670 patients, this is “the largest cohort study to date looking specifically at the association of [HCQ] retinopathy with risk factors,” one expert said. Medscape Medical News
US FDA Approves Two Biosimilars for Blockbuster Eye Drug Eylea
The U.S. Food and Drug Administration (FDA) on Monday approved two close copies of Regeneron Pharmaceuticals’ Eylea, its first-ever clearance to biosimilar versions of the… Reuters Health Information
The Lure of Specialty Medicine Pulls NPs From Primary Care
Nurse practitioners and physician assistants are joining cardiology, dermatology, and other specialty practices to broaden their skills and increase their income. KFF Health News
Imaging Techniques May Match Gold Standard for Retinal Tears
Options beyond dilated fundus exams could ease access to care. Medscape Medical News
Opinion: The Immunology of COVID and the Future
A leading light in immunobiology takes us through long COVID, nasal vaccines, and the next frontier of the field. Medscape
Ultrasound-Aided Diagnosis of GCA Is Accurate, Avoids Biopsy
In a prospective study, all patients diagnosed with giant cell arteritis using ultrasound maintained their diagnosis for up to 2 years of follow-up. Medscape Medical News
Open-Angle Glaucoma Dx: Polygenic Risk Score Found Useful
This study is the first to assess clinical utility of a polygenic risk score for diagnosing primary open-angle glaucoma, researchers said. Medscape Medical News
Revamped Antibiotic May Treat Deadly Eye Infection
Topical cefiderocol “could be a new weapon in the ophthalmologist’s arsenal” to combat a strain of bacteria found last year in bottles of artificial tears, researchers report at ARVO 2024. Medscape Medical News
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Unlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation. Medscape Medical News